Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab

Abstract

Dupilumab resolved alopecia totalis in a 13-year-old girl treated for severe atopic dermatitis (AD).1 The resolution of AD by dupilumab has been reported in children under the US Food and Drug Administration's approved age of 6 years and older.2 These cases highlight dupilumab's ability to suppress the helper T cell type 2 (Th2) immune axis in children. Herein, we report full scalp hair regrowth in a 4-year-old girl with severe AD with concomitant alopecia areata (AA) treated with dupilumab.

Topics & Concepts